TAHL CINDY Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
26
Insider Sells Sum
$32.03M

Insider Activity of TAHL CINDY

According to the SEC Form 4 filings, TAHL CINDY, being in a position of

  1. See Remarks at Fate Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 74979 shares for $154,764,
    over all time since 2017-10-13, has bought 0 shares, and sold 897616 shares for $32.2M.

Biography of TAHL CINDY

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $154,7643100

Comparison of Insiders on Amount of Buys and Sells

2026-08-04SaleFate Therapeutics, Inc.
FATE
See Remarks
38,800
0.0318%
$2.46$95,405-7.39%
2026-05-20SaleFate Therapeutics, Inc.
FATE
See Remarks
25,590
0.0224%
$1.88$48,084+30.98%
2026-01-09SaleFate Therapeutics, Inc.
FATE
See Remarks
10,589
0.0093%
$1.06$11,275+96.19%
2025-08-04SaleFate Therapeutics, Inc.
FATE
See Remarks
9,037
0.0078%
$1.06$9,573+16.04%
2025-01-10SaleFate Therapeutics, Inc.
FATE
See Remarks
5,654
0.0052%
$1.55$8,764-23.81%
2024-01-09SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
10,874
0.0109%
$4.37$47,519-14.74%
2023-11-09SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
24,363
0.0278%
$2.40$58,471+78.4%
2023-01-10SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
11,553
0.0112%
$5.24$60,538-13.84%
2022-06-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
25,000
0.0262%
$22.96$574,000-15.51%
2022-04-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
25,000
0.0243%
$38.85$971,250-47.83%
2022-01-11SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
5,419
0.0057%
$48.53$262,975-43.63%
2022-01-10SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
7,738
0.0076%
$46.43$359,313-45.37%
2022-01-03SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
50,000
0.0511%
$59.34$2.97M-54.33%
2021-10-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
50,000
0.0522%
$58.83$2.94M-41.8%
2021-07-01SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
55,534
0.0526%
$85.24$4.73M-47.21%
2021-04-01SaleFate Therapeutics, Inc.
FATE
See Remarks
30,000
0.0325%
$83.81$2.51M-23.68%
2021-01-19SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
35,000
0.0376%
$114.76$4.02M-32.99%
2021-01-11SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
3,254
0.0034%
$110.81$360,587-31.03%
2021-01-08SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
6,229
0.0067%
$117.10$729,434-33.06%
2020-11-05SaleFate Therapeutics, Inc.
FATE
General Counsel and Secretary
38,564
0.0448%
$50.63$1.95M+65.36%
Total: 30
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.